Macular edema after cataract surgery
Tartalom
PubMed: Szakterületek: Purpose: To compare the efficacy of perioperative treatment strategies, in addition to topical bromfenac 0. Setting: Twelve European study centers.
Design: Randomized clinical trial. Methods: Diabetic patients having phacoemulsification cataract surgery were randomly allocated to receive no additional treatment, a subconjunctival injection with 40 mg triamcinolone acetonide, an intravitreal injection with 1.
- Huba Kiss, MD, PhD - Google Scholar
- Méhlátó videó
- Huba Kiss, MD, PhD - Google Tudós
The main outcomes were the difference in central subfield mean macular thickness, corrected distance visual acuity, and the incidence of CME and clinically significant macular edema within 6 and 12 weeks postoperatively.
Results: The study comprised patients.
At 6 and 12 weeks postoperatively, the central subfield mean macular thickness was No patient who received subconjunctival triamcinolone acetonide developed CME. Intravitreal bevacizumab had no significant effect on macular thickness.
Conclusions: Diabetic patients who received a subconjunctival injection with triamcinolone acetonide at the end of cataract surgery had a lower macular thickness and macular volume at 6 and 12 weeks postoperatively than patients who did not.
Intravitreal bevacizumab had no significant effect.